Changes in Health-Related Quality of Life in Patients with Primary Immunodeficiency Disorder (PIDD) Between Time of Diagnosis and 12 Months after Initiation of Immunoglobulin (Ig) Therapy - 03/02/15
Doi : 10.1016/j.jaci.2014.12.1381
John M. Routes, MD, FAAAAI 1, Beatriz T.C. Carvalho 2, Bodo Grimbacher, MD 3, Kenneth Paris, MD, MPH 4, Hans D. Ochs, MD 5, Alexandra H. Filipovich, MD 6, Diane Ito, MA 7, Yan Xiong, MS 7, Josephine Li-McLeod, PhD 7, Patrick Bonnet, PharmD 7
1 Medical College of Wisconsin, Milwaukee, WI
2 Federal University of São Paulo
3 Royal Free Hospital & University College, London, United Kingdom
4 LSU Health Sciences Center, New Orleans, New Orleans, LA
5 University of Washington, Seattle, WA
6 Cincinnati Children's Hospital Medical Center, Cincinnati, OH
7 Baxter Healthcare Corporation, Westlake Village, CA
442
Le texte complet de cet article est disponible en PDF.Plan
© 2015
Publié par Elsevier Masson SAS.
Vol 135 - N° 2S
P. AB137 - février 2015 Retour au numéro
Article précédent
- Factors Driving Perceived Health Status Among Patients with Primary Immune Deficiency
- Filiz Odabasi Seeborg, Roann Seay, Marcia Boyle, Christopher Scalchunes, Jordan S. Orange
- Association of Sports Activities and Rhinitis Symptoms in Schoolchildren Is Influenced By Comorbidities of Eczema
- Takashi Kusunoki, Jiro Takeuchi, Takeshi Morimoto, Mio Sakuma, Kumiko Mukaida, Takahiro Yasumi, Ryuta Nishikomori, Toshio Heike
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?